Frequency of CDH1 germline mutations in diffuse gastric cancer in Brazil.

Authors

null

Rodrigo Santa Cruz Guindalini

Instituto Do Cancer Do Estado De Sao Paulo, Sao Paulo, Brazil

Rodrigo Santa Cruz Guindalini , Fatima Solange Pasini , Ana Carolina Ribeiro Chaves De Gouvea , Priscila Abduch Branas , Marina Candido Visontai Cormedi , Simone Maistro , Maria Lucia Hirata Katayama , Giselly Encinas , Tauana Nagy , Maria Del Pilar Estevez-Diz , Adriana Vaz Safatle-Ribeiro , Ulysses Ribeiro , Maria A. A. Koike Folgueira

Organizations

Instituto Do Cancer Do Estado De Sao Paulo, Sao Paulo, Brazil, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil, Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, Brazil, Faculdade de Medicina da USP, São Paulo, Brazil, Disciplina de Oncologia, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil, Departamento de Radiologia e Oncologia, Faculdade de Medicina Universidade de São Paulo, São Paulo, Brazil, Departamento de Radiologia e Oncologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, Faculdade De Medicina Da USP, São Paulo, Brazil, Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil, Instituto Do Câncer Do Estado De São Paulo, São Paulo, Brazil, University of São Paulo, São Paulo, Brazil, Departamento de Radiologia e Oncologia, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil

Research Funding

No funding sources reported

Background: Although hereditary diffuse gastric cancer syndrome is a rare condition its contribution to gastric cancer burden in Brazil is unknown. The aim of this study was to examine the frequency of CDH1 germline mutations in a population-based series of diffuse gastric cancer (DGC) in Brazil, which is considered a middle/high-incidence country for gastric cancer. Methods: From October 2013 to October 2014 a total of 64 unrelated and consecutive patients attending a Brazilian public hospital with DGC were enrolled and all CDH1 exons and intronic boundaries were sequenced. Clinico-pathological features were extracted from electronic medical records. Recruitment for this study is still ongoing. Results: Of 64 patients, 57.8% were female and the mean age at gastric cancer diagnosis was 46.6 years (range 21-76); 17% reported family history of gastric cancer in first- or second-degree relatives, 39% were diagnosed ≤ 40 years old, and none of them fulfilled the original 1999 International Gastric Cancer Linkage Consortium criteria for genetic testing. The majority of the tumors were poorly differentiated (84%), and located in the middle and distal-third of the stomach (70%). One germline deleterious mutation (c.1849G>A, p.A617T) was identified in 2 unrelated female patients with DGC (42 years and 47 years) and without family history of gastric cancer (Table 1). The overall frequency of germline CDH1 mutations was 3.1% (2/64) for DGC. Conclusions: To our knowledge, this is the largest population-based study investigating the contribution of CDH1 germline mutations in DGC cancer in Brazil. For a middle/high-incidence country, mutation frequency was higher than expected. This finding warrants further validation in larger cohort studies.

Clinical characteristics of CDH1 mutation carriers.

AgeSexStagePartGradeMucinousHpFam hist
42 yoFIVbodyPoorly differentiatedyesN/Ano
47 yoFIIbpylorusPoorly differentiatednopositiveno

Abbreviations: F, female; Hp, Helicobacter pylori; Fam hist, family history of gastric cancer in first- or second-degree relatives; N/A, not available; yo, years old.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2015 ASCO Annual Meeting

Session Type

Publication Only

Session Title

Publication Only: Cancer Prevention, Genetics, and Epidemiology

Track

Prevention, Risk Reduction, and Genetics

Sub Track

Cancer Genetics

Citation

J Clin Oncol 33, 2015 (suppl; abstr e12535)

DOI

10.1200/jco.2015.33.15_suppl.e12535

Abstract #

e12535

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Annual Meeting

CDH1 incidental findings in patients with personal or family history of breast cancer.

First Author: Hiam Abdel-Salam

Abstract

2024 ASCO Annual Meeting

Clinical and genomic characteristics of multiple primary lung cancers with germline mutations.

First Author: Yingshun Yang

Abstract

2014 Gastrointestinal Cancers Symposium

Searching for CDH1 gene mutations in early-onset diffuse gastric cancer in Chinese patients.

First Author: Xu Yanjun

Abstract

2023 ASCO Gastrointestinal Cancers Symposium

The Gastric Cancer Registry Genome Explorer: A tool for genomic discovery.

First Author: Alison Figueroa Almeda